These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15320475)

  • 1. Endothelin receptor antagonists: a new therapeutic option for improving the outcome after solid organ transplantation?
    Göttmann U; van der Woude FJ; Braun C
    Curr Vasc Pharmacol; 2003 Oct; 1(3):281-99. PubMed ID: 15320475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathophysiology of endothelin in complications after solid organ transplantation: a potential novel therapeutic role for endothelin receptor antagonists.
    Raina A; Horn ET; Benza RL
    Transplantation; 2012 Nov; 94(9):885-93. PubMed ID: 23037008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist.
    Braun C; Conzelmann T; Vetter S; Schaub M; Back WE; Yard B; Kirchengast M; Tullius SG; Schnülle P; van der Woude FJ; Rohmeiss P
    Transplantation; 1999 Sep; 68(6):739-46. PubMed ID: 10515373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin receptor antagonists and cardiovascular diseases of aging.
    Love MP; McMurray JJ
    Drugs Aging; 2001; 18(6):425-40. PubMed ID: 11419917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W; Pittrow D
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with a combined endothelin A/B-receptor antagonist does not prevent chronic renal allograft rejection in rats.
    Braun C; Conzelmann T; Vetter S; Schaub M; Back WE; Kirchengast M; Tullius SG; Schnülle P; van der Woude FJ; Rohmeiss P
    J Cardiovasc Pharmacol; 2000 Oct; 36(4):428-37. PubMed ID: 11026642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin receptor antagonists. Promising new agents in the management of cardiovascular disorders.
    Goddard J; Webb DJ
    Drugs R D; 1999 Jul; 2(1):1-12. PubMed ID: 10560541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin antagonists.
    Benigni A; Remuzzi G
    Lancet; 1999 Jan; 353(9147):133-8. PubMed ID: 10023915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin and endothelin antagonists in hypertension.
    Schiffrin EL
    J Hypertens; 1998 Dec; 16(12 Pt 2):1891-5. PubMed ID: 9886874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders.
    Spieker LE; Noll G; Lüscher TF
    Am J Cardiovasc Drugs; 2001; 1(4):293-303. PubMed ID: 14728028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation.
    Herrero I; Torras J; Riera M; Condom E; Coll O; Cruzado JM; Hueso M; Bover J; Lloberas N; Alsina J; Grinyó JM
    Nephrol Dial Transplant; 1999 Apr; 14(4):872-80. PubMed ID: 10328462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin in cardiovascular control: the role of endothelin antagonists.
    Wenzel RR; Czyborra P; Lüscher T; Philipp T
    Curr Hypertens Rep; 1999; 1(1):79-87. PubMed ID: 10981046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system.
    Doggrell SA
    Expert Opin Investig Drugs; 2002 Nov; 11(11):1537-52. PubMed ID: 12437501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
    Hay DW; Luttmann MA; Beck G; Ohlstein EH
    Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical potential of endothelin receptor antagonists in cardiovascular medicine.
    Ferro CJ; Webb DJ
    Drugs; 1996 Jan; 51(1):12-27. PubMed ID: 8741230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P
    Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelins and the lung.
    Boscoe MJ; Goodwin AT; Amrani M; Yacoub MH
    Int J Biochem Cell Biol; 2000 Jan; 32(1):41-62. PubMed ID: 10661893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin(A) receptor blockade reduces ischemia/reperfusion injury in pig pancreas transplantation.
    Witzigmann H; Ludwig S; Armann B; Gäbel G; Teupser D; Kratzsch J; Pietsch UC; Tannapfel A; Geissler F; Hauss J; Uhlmann D
    Ann Surg; 2003 Aug; 238(2):264-74. PubMed ID: 12894021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New expansion of endothelin research: perspectives for clinical application of endothelin-receptor antagonists].
    Goto K; Miyauchi T
    Nihon Yakurigaku Zasshi; 2003 Feb; 121(2):91-101. PubMed ID: 12616854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin in organ transplantation.
    Watschinger B; Sayegh MH
    Am J Kidney Dis; 1996 Jan; 27(1):151-61. PubMed ID: 8546132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.